Policy and program analysis using administrative databases

Annals of Internal Medicine

Volumn 127, Issue 8 II SUPPL., 1997, Pages 712-718

  Ray, Wayne A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DATA ANALYSIS; DATA BASE; HEALTH CARE POLICY; HEALTH PROGRAM; MEDICAL RECORD; MEDICARE; OUTCOMES RESEARCH; PRIORITY JOURNAL;

EID: 0030798527     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-8_part_2-199710151-00055     Document Type: Conference Paper

References (37)

1. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin TJ, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991;325:1072-7.
2. Lipton HL, Bird JA. Drug utilization review in ambulatory settings: state of the science and directions for outcomes research. Med Care. 1993:31:1069-82.
3. Soumerai SB, Lipton HL. Computer-based drug-utilization review - risk, benefit, or boondoggle? N Engl J Med. 1995;332:1641-5.
4. Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. 21st ed. New York: Oxford Univ Pr; 1992:1-351.
5. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol. 1989;129:837-49.
6. Strom BL, Carson JL. Use of automated databases for pharmacoepidemiologic research. Epidemiol Rev. 1990;12:87-107.
7. Shapiro S. The role of automated record linkage in the postmarketing surveillance of drug safety: a critique. Clin Pharmacol Ther. 1989;46:371-86.
8. Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol. 1989;42:937-45.
9. Stergachis AS. Record linkage studies for postmarketing drug surveillance: data quality and validity considerations. Drug Intell Clin Pharm. 1988;22:157-61.
10. Fisher ES, Baron JA, Malenka DJ, Barrett J, Bubolz TA. Overcoming potential pitfalls in the use of Medicare data for epiderniologic research. Am J Public Health. 1990;80:1487-90.
11. Ruther M, Pagan BA, Rinkle V, Yanck J. Program Statistics: Medicare and Medicaid Data Book, 1984. Baltimore: Health Care Financing Administration; 1986.
12. Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of OBRA-87. JAMA. 1994;271:358-62.
13. Smalley WE, Griffin MR, Fought RL, Sullivan L, Ray WA. Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients. N Engl J Med. 1995;332:1612-7.
14. Welch WP, Miller ME, Welch HG, Fisher ES, Wennberg JE. Geographic variation in expenditures for physicians' services in the United States. N Engl J Med. 1993;328:621-7.
15. Caper P. Solving the medical care dilemma. N Engl J Med. 1988;318:1535-6.
16. Cherry JK, Carmichael DB, Shean FC, Ritt DJ. Inaccurate data in "Solving the medical care dilemma." N Engl J Med. 1988;319:800-1.
17. Soumerai SB, Ross-Degnan D, Fortess EE, Abelson J. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Milbank Q. 1993;71:217-52.
18. Cook TD, Campbell DT. Quasi-experimentation. Design & analysis issues for field settings. Boston: Houghton Mifflin; 1979:1-405.
19. Drug Facts and Comparisons. St. Louis, MO: Facts and Comparisons; 1992.
20. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs - differences and similarities. N Engi J Med. 1991;324:1716-25.
21. Institute of Medicine. Preventing Low Birthweight. Washington, DC: National Academy Pr; 1985.
22. Sardell A. Child health policy in the U.S.: the paradox of consensus. J Health Polit Policy Law. 1990;15:271-304.
23. Torres A, Kenney AM. Expanding Medicaid coverage for pregnant women: estimates of the impact and cost. Fam Plann Perspect. 1989;21:19-24.
24. Ray WA, Mitchel EF Jr, Piper JM. Effect of Medicaid expansions on preterm birth. Am J Prev Med. 1997;13:292-7.
25. Kessner DM, Singer J, Kalk CE, Schlesinger ER. Infant death: an analysis by maternal risk and health care: Panel on Health Services Research, Institute of Medicine. Washington, DC: National Academy Pr; 1973.
26. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986;314:1657-64.
27. Park RE, Brook RH, Kosecoff J, Keesey J, Ruhenstein L, Keeler E, et al. Explaining variations in hospital death rates. JAMA. 1990;264:484-90.
28. Pollack MM, Ruttimann UE, Getson PR. Accurate prediction of the outcome of pediatric intensive care. A new quantitative method. N Engl J Med, 1987;316:134-9.
29. Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol. 1995;141:539-45.
30. Smalley WE, Griffin MR, Fought RL, Ray WA. Excess costs for gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs. J Gen Intern Med. 1996;11:461-9.
31. Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989;320:1120-4.
32. Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. JAMA. 1992;267:1077-82.
33. Ray WA, Taylor JA, Lichtenstein MJ, Meador KG. The nursing home behavior problem scale. J Gerontol. 1992;47:M9-16.
34. Meador KG, Taylor JA, Thapa PB, Fought RL, Ray WA. Predictors of antipsychotic withdrawal or dose reduction in a randomized controlled trial of provider education. J Am Geriatr Soc. 1997;45:207-10.
35. Oster G, Borok GM, Menzin J, Heys JF, Epstein RS, Quinn V, et al. A randomized trial to assess effectiveness and cost in clinical practice: rationale and design of the Cholesterol Reduction Intervention Study (CRIS). Control Clin Trials. 1995;16:3-16.
36. Stuck AE, Aronow HU, Steiner A, Alessi CA, Bula CJ, Gold MN, et al. A trial of annual in-home comprehensive geriatric assessments for elderly people living in the community. N Engl J Med. 1995;333:1184-9.
37. Rich MW, Beckham V, Wittenberg C, Leven CL, Freeland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-5.